This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 March-2 April 2022, and includes updates on COVID-19, the influx of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, seasonal influenza, Crimean-Congo haemorrhagic fever, and poliomyelitis.
This document assesses the risk of further spread of S. sonnei amongst MSM and in the broader population in EU/EEA countries, resulting from the current increase in extensively-drug resistant S. sonnei infections.